Abstract
Abstract: It has been reported that high‐dose administration of intravenous immunoglobulin (IVIG) is useful for the inhibition of complement‐dependent immune cytolysis, which is the first event of xenogeneic hyperacute rejection. We have found that monomeric peptide residues 289–292 and 282–292 from the second constant domain of the γ‐chain of the human IgG, part of the Clq binding sites, was also effective in inhibition of pig RBC lysis by human serum, and IgM‐rich IVIG (Pentaglobulin) was more active than IVIG in this assay.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
